000872541 001__ 872541
000872541 005__ 20230117082039.0
000872541 0247_ $$2doi$$a10.1111/1751-7915.13525
000872541 0247_ $$2ISSN$$a1751-7907
000872541 0247_ $$2ISSN$$a1751-7915
000872541 0247_ $$2Handle$$a2128/24433
000872541 0247_ $$2altmetric$$aaltmetric:73781372
000872541 0247_ $$2pmid$$apmid:31880860
000872541 0247_ $$2WOS$$aWOS:000504538600001
000872541 037__ $$aFZJ-2020-00059
000872541 082__ $$a610
000872541 1001_ $$00000-0001-9998-1846$$aBecker, Johanna$$b0
000872541 245__ $$aAn Ustilago maydis chassis for itaconic acid production without by‐products
000872541 260__ $$aOxford$$bWiley-Blackwell$$c2020
000872541 3367_ $$2DRIVER$$aarticle
000872541 3367_ $$2DataCite$$aOutput Types/Journal article
000872541 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1583158631_24314
000872541 3367_ $$2BibTeX$$aARTICLE
000872541 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000872541 3367_ $$00$$2EndNote$$aJournal Article
000872541 500__ $$aBiotechnologie 1
000872541 520__ $$aUstilago maydis is a promising yeast for the production of a range of valuable metabolites, including itaconate, malate, glycolipids and triacylglycerols. However, wild‐type strains generally produce a potpourri of all of these metabolites, which hinders efficient production of single target chemicals. In this study, the diverse by‐product spectrum of U. maydis was reduced through strain engineering using CRISPR/Cas9 and FLP/FRT, greatly increasing the metabolic flux into the targeted itaconate biosynthesis pathway. With this strategy, a marker‐free chassis strain could be engineered, which produces itaconate from glucose with significantly enhanced titre, rate and yield. The lack of by‐product formation not only benefited itaconate production, it also increases the efficiency of downstream processing improving cell handling and product purity.
000872541 536__ $$0G:(DE-HGF)POF3-581$$a581 - Biotechnology (POF3-581)$$cPOF3-581$$fPOF III$$x0
000872541 588__ $$aDataset connected to CrossRef
000872541 7001_ $$0P:(DE-Juel1)176855$$aHosseinpour Tehrani, Hamed$$b1
000872541 7001_ $$0P:(DE-HGF)0$$aGauert, Marc$$b2
000872541 7001_ $$0P:(DE-HGF)0$$aMampel, Jörg$$b3
000872541 7001_ $$0P:(DE-HGF)0$$aBlank, Lars M.$$b4
000872541 7001_ $$0P:(DE-Juel1)176653$$aWierckx, Nick$$b5$$eCorresponding author
000872541 773__ $$0PERI:(DE-600)2406063-X$$a10.1111/1751-7915.13525$$gp. 1751-7915.13525$$n2$$p350 - 362$$tMicrobial biotechnology$$v13$$x1751-7915$$y2020
000872541 8564_ $$uhttps://juser.fz-juelich.de/record/872541/files/Rechnung_R-2019-00444.pdf
000872541 8564_ $$uhttps://juser.fz-juelich.de/record/872541/files/Becker%20et%20al%202019%20Microb%20Biotechnol%201-13.pdf$$yOpenAccess
000872541 8564_ $$uhttps://juser.fz-juelich.de/record/872541/files/Rechnung_R-2019-00444.pdf?subformat=pdfa$$xpdfa
000872541 8564_ $$uhttps://juser.fz-juelich.de/record/872541/files/Becker%20et%20al%202019%20Microb%20Biotechnol%201-13.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000872541 8767_ $$8R-2019-00444$$92020-02-27$$d2020-03-04$$eAPC$$jDeposit$$lDEAL: Wiley$$pMBT213525$$zRechnung von MPDL erhalten
000872541 909CO $$ooai:juser.fz-juelich.de:872541$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
000872541 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)176653$$aForschungszentrum Jülich$$b5$$kFZJ
000872541 9131_ $$0G:(DE-HGF)POF3-581$$1G:(DE-HGF)POF3-580$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lKey Technologies for the Bioeconomy$$vBiotechnology$$x0
000872541 9141_ $$y2020
000872541 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000872541 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000872541 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000872541 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000872541 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMICROB BIOTECHNOL : 2017
000872541 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000872541 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000872541 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000872541 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000872541 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000872541 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000872541 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review
000872541 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000872541 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000872541 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000872541 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000872541 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000872541 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000872541 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
000872541 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
000872541 920__ $$lyes
000872541 9201_ $$0I:(DE-Juel1)IBG-1-20101118$$kIBG-1$$lBiotechnologie$$x0
000872541 980__ $$ajournal
000872541 980__ $$aVDB
000872541 980__ $$aUNRESTRICTED
000872541 980__ $$aI:(DE-Juel1)IBG-1-20101118
000872541 980__ $$aAPC
000872541 9801_ $$aAPC
000872541 9801_ $$aFullTexts